Response Gene to Complement 32 (RGC-32) in Disease
The invention relates to antibodies that bind to a fragment of the Response Gene to Complement-32 (RGC-32), as well as methods of using these antibodies. Particular methods of using the antibodies of the present invention include, but are not limited to, methods of detecting RGC-32 in a sample, methods of assaying cell proliferation, as well as methods of detecting and/or monitoring the progression of abnormal conditions in a subject, where the disease states are associated with the presence or absence of RGC-32.
US 20,110,034,344 [MORE INFO
RUS HOREA [US]; BADEA TUDOR [US]; FOSBRINK MATTHEW [US]
Type of Offer:
« More Biotech Patents